[go: up one dir, main page]

RU2006138362A - Новая кристаллическая форма 8-циано-1-циклопропил-7-(1s, 6s-2, 8-диазабицикло-(4. 3. 0)нонан-8-ил)-6-фтор-1, 4-дигидро-4-оксо-3-хинолинкарбоновой кислоты - Google Patents

Новая кристаллическая форма 8-циано-1-циклопропил-7-(1s, 6s-2, 8-диазабицикло-(4. 3. 0)нонан-8-ил)-6-фтор-1, 4-дигидро-4-оксо-3-хинолинкарбоновой кислоты Download PDF

Info

Publication number
RU2006138362A
RU2006138362A RU2006138362/04A RU2006138362A RU2006138362A RU 2006138362 A RU2006138362 A RU 2006138362A RU 2006138362/04 A RU2006138362/04 A RU 2006138362/04A RU 2006138362 A RU2006138362 A RU 2006138362A RU 2006138362 A RU2006138362 A RU 2006138362A
Authority
RU
Russia
Prior art keywords
digydro
nonan
fluor
diazabicyclo
cyclopropyl
Prior art date
Application number
RU2006138362/04A
Other languages
English (en)
Other versions
RU2383543C2 (ru
Inventor
Хуберт РАСТ (DE)
Хуберт Раст
Ирис ХЕЕП (DE)
Ирис ХЕЕП
Альфонс ГРУНЕНБЕРГ (DE)
Альфонс Груненберг
Вернер ХАЛЛЕНБАХ (DE)
Вернер Халленбах
Хорди БЕННЕТ-БУХХОЛЬЦ (ES)
Хорди БЕННЕТ-БУХХОЛЬЦ
Original Assignee
Байер ХельсКер АГ (DE)
Байер ХельсКер АГ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер ХельсКер АГ (DE), Байер ХельсКер АГ filed Critical Байер ХельсКер АГ (DE)
Publication of RU2006138362A publication Critical patent/RU2006138362A/ru
Application granted granted Critical
Publication of RU2383543C2 publication Critical patent/RU2383543C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Claims (3)

1. Тригидрат прадофлоксацина.
2. Фармацевтическая композиция с антибактериальным действием, содержащая тригидрат прадофлоксацина по п.1.
3. Применение тригидрата прадофлоксацина по п.1 для получения антибактериального лекарственного средства.
RU2006138362/04A 2004-04-01 2005-03-19 Тригидрат 8-циано-1-циклопропил-7-(1s, 6s-2,8-диазабицикло-[4.3.0]нонан-8-ил)-6-фтор-1, 4-дигидро-4-оксо-3-хинолинкарбоновой кислоты RU2383543C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004015981.5 2004-04-01
DE102004015981A DE102004015981A1 (de) 2004-04-01 2004-04-01 Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (2)

Publication Number Publication Date
RU2006138362A true RU2006138362A (ru) 2008-05-10
RU2383543C2 RU2383543C2 (ru) 2010-03-10

Family

ID=34962324

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006138362/04A RU2383543C2 (ru) 2004-04-01 2005-03-19 Тригидрат 8-циано-1-циклопропил-7-(1s, 6s-2,8-диазабицикло-[4.3.0]нонан-8-ил)-6-фтор-1, 4-дигидро-4-оксо-3-хинолинкарбоновой кислоты

Country Status (31)

Country Link
US (1) US7977484B2 (ru)
EP (1) EP1737859B1 (ru)
JP (1) JP5190259B2 (ru)
KR (1) KR101217678B1 (ru)
CN (1) CN100591681C (ru)
AR (2) AR048099A1 (ru)
AT (1) ATE450536T1 (ru)
AU (1) AU2005231918B2 (ru)
BR (1) BRPI0509529B8 (ru)
CA (1) CA2561635C (ru)
CY (2) CY1109762T1 (ru)
DE (3) DE102004015981A1 (ru)
DK (1) DK1737859T3 (ru)
ES (1) ES2335899T3 (ru)
GT (1) GT200500043A (ru)
HR (1) HRP20100097T1 (ru)
IL (1) IL178353A (ru)
MY (1) MY140998A (ru)
NO (1) NO337279B1 (ru)
NZ (1) NZ550226A (ru)
PE (1) PE20060170A1 (ru)
PL (1) PL1737859T3 (ru)
PT (1) PT1737859E (ru)
RU (1) RU2383543C2 (ru)
SI (1) SI1737859T1 (ru)
SV (1) SV2006002070A (ru)
TW (1) TWI350755B (ru)
UA (1) UA84329C2 (ru)
UY (1) UY28828A1 (ru)
WO (1) WO2005097789A1 (ru)
ZA (1) ZA200608072B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
CN110248643B (zh) 2017-02-13 2023-11-24 拜耳动物保健有限责任公司 含普拉沙星的液体组合物
CN115710267A (zh) * 2022-11-30 2023-02-24 天津大学 一种普拉沙星水合物晶体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
HU228036B1 (en) 1996-02-23 2012-08-28 Bayer Animal Health Gmbh Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives, process producing them and medicaments thereof
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
JP2007530614A (ja) 2007-11-01
NO20064988L (no) 2006-10-31
CA2561635A1 (en) 2005-10-20
UY28828A1 (es) 2005-11-30
US20080125458A1 (en) 2008-05-29
SV2006002070A (es) 2006-03-15
DE122011100055I1 (de) 2012-03-15
SI1737859T1 (sl) 2010-03-31
WO2005097789A1 (de) 2005-10-20
KR101217678B1 (ko) 2013-01-02
CN1938304A (zh) 2007-03-28
CN100591681C (zh) 2010-02-24
HRP20100097T1 (hr) 2010-04-30
IL178353A (en) 2011-08-31
EP1737859B1 (de) 2009-12-02
EP1737859A1 (de) 2007-01-03
HK1104537A1 (en) 2008-01-18
AU2005231918A1 (en) 2005-10-20
US7977484B2 (en) 2011-07-12
AU2005231918B2 (en) 2011-05-12
AR048099A1 (es) 2006-03-29
DE102004015981A1 (de) 2005-10-20
DE502005008620D1 (de) 2010-01-14
AR105177A2 (es) 2017-09-13
UA84329C2 (en) 2008-10-10
KR20070014157A (ko) 2007-01-31
PL1737859T3 (pl) 2010-04-30
JP5190259B2 (ja) 2013-04-24
ATE450536T1 (de) 2009-12-15
NO337279B1 (no) 2016-02-29
PE20060170A1 (es) 2006-04-13
TWI350755B (en) 2011-10-21
TW200602053A (en) 2006-01-16
RU2383543C2 (ru) 2010-03-10
ES2335899T3 (es) 2010-04-06
CY1109762T1 (el) 2014-09-10
CA2561635C (en) 2012-10-16
NZ550226A (en) 2009-11-27
BRPI0509529A (pt) 2007-09-18
IL178353A0 (en) 2007-02-11
BRPI0509529B1 (pt) 2019-05-21
CY2011018I1 (el) 2016-12-14
MY140998A (en) 2010-02-12
DK1737859T3 (da) 2010-04-06
GT200500043A (es) 2006-02-17
PT1737859E (pt) 2010-02-03
BRPI0509529B8 (pt) 2021-05-25
ZA200608072B (en) 2008-01-08

Similar Documents

Publication Publication Date Title
GEP20105082B (en) (biphenyl) carboxylic acids and derivatives thereof
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085067L (no) 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085066L (no) 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
CL2007002018A1 (es) Compuestos derivados de isoxazolinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de una enfermedad causada por un aumento en la proliferacion celular.
HRP20171175T1 (hr) Novi triciklički spojevi
EA200970726A1 (ru) Твердый препарат, содержащий алоглиптин и пиоглитазон
IL190643A0 (en) Novel dihydropseudoerythromycin derivatives
GEP20084468B (en) Gamma-d crystalline form of ivabradin hydrochloride, process for its preparation and pharmaceutical compositions containing it
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
CA2530308A1 (en) 5ht2c receptor agonists for the treatment of diabetes and obesity
CL2007000680A1 (es) Compuesto cristalino (5s)-5-[4(cloro-piridin-2-iloxi)-piperidin-1-sulfonilmetil]-5-metil-imidazolidin-2,4-diona, forma g; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento de epoc.
JP2008513510A5 (ru)
WO2008098978A3 (en) Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
WO2013128419A3 (en) Pharmaceutical compositions comprising boronic acid compounds
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
CA2494601A1 (en) N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
WO2005118579A3 (en) Thiazole derivatives as chemokine receptor antagonists
RU2006138362A (ru) Новая кристаллическая форма 8-циано-1-циклопропил-7-(1s, 6s-2, 8-диазабицикло-(4. 3. 0)нонан-8-ил)-6-фтор-1, 4-дигидро-4-оксо-3-хинолинкарбоновой кислоты
NZ609596A (en) Cyclohexane derivative compound
WO2009071691A3 (de) Oxindol-derivate und ihre verwendung als medikament
HRP20130983T1 (hr) Derivati arilciklopropilacetamida, korisni kao aktivatori glukokinaze
DE60300683D1 (de) Prucaloprid-n-oxid
RU2005140621A (ru) Гемостатическое средство

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20130207